Loading...
Header Logo
Keywords
Last Name
Institution

Trudy G Morrison PhD

TitleProfessor
InstitutionUniversity of Massachusetts Medical School
DepartmentMicrobiology and Physiological Systems
AddressUniversity of Massachusetts Medical School
55 Lake Avenue North
Worcester MA 01655
Phone508-856-6592
vCardDownload vCard
    Other Positions
    InstitutionUMMS - School of Medicine
    DepartmentMicrobiology and Physiological Systems

    InstitutionUMMS - Graduate School of Biomedical Sciences
    DepartmentImmunology and Virology

    InstitutionUMMS - Graduate School of Biomedical Sciences
    DepartmentMD/PhD Program

    InstitutionUMMS - Graduate School of Biomedical Sciences
    DepartmentMolecular Genetics and Microbiology

    InstitutionUMMS - Programs, Centers and Institutes
    DepartmentCenter for AIDS Research


    Collapse Biography 
    Collapse education and training
    Wellesley College, Wellesley, MA, United StatesBABiology
    Tufts University School of Medicine, Boston, MA, United StatesPHDMicrobiology/Molecular Biology

    Collapse Overview 
    Collapse overview

    Academic Background

    B.A. Wellesley College
    Ph. D.Tufts University School of Medicine
    Postdoctoral training at Massachusetts Institute of Technology

    Dr. Trudy Morrison

    Mechanisms of Paramyxovirus Membrane Fusion
    Assembly of Paramyxoviruses
    Development of Virus Vaccines

    My laboratory is exploring the molecular mechanisms of paramyxovirus entry into susceptible cells and the assembly and release of infectious virus from infected cells. Paramyxoviruses are simple negative-stranded, enveloped RNA viruses. The two viral glycoproteins, the hemagglutinin-neuraminidase (HN) protein and the fusion (F) protein, mediate entry of the virus into cells. The HN protein is the virus attachment protein and the F protein directly mediates the membrane fusion required for virus penetration. However, the HN protein is required to activate the fusion activity of the F protein. Using Newcastle disease virus as a model paramyxovirus, my laboratory is exploring the molecular mechanisms involved in the activation of the fusion protein and the requirements for the conformational changes in the F protein required to mediate membrane fusion.

    Release of progeny paramyxoviruses from infected cells requires the assembly of the structural components of the virion, the viral glycoproteins, the matrix protein, and the ribonucleoprotein core, followed by the budding of mature virus from surfaces of infected cells. We are exploring the protein interactions required for the formation of assembly complexes, the cell domains involved in virus assembly, and the host cell contributions to virus assembly and release.

    My laboratory is also exploring the potential of virus-like particles as vaccines for different paramyxoviruses.




    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Cullen LM, Schmidt MR, Morrison TG. The Importance of RSV F Protein Conformation in VLPs In Stimulation of Neutralizing Antibody Titers in Mice Previously Infected with RSV. Hum Vaccin Immunother. 2017 Jun 12; 0. PMID: 28604155.
      View in: PubMed
    2. Cullen LM, Blanco JC, Morrison TG. Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein. J Transl Med. 2015 Nov 05; 13:350. PMID: 26541285.
      View in: PubMed
    3. Morrison TG. Protein conformation in a vaccine matters. Oncotarget. 2015 Sep 8; 6(26):21781-2. PMID: 26318167.
      View in: PubMed
    4. McGinnes Cullen L, Schmidt MR, Kenward SA, Woodland RT, Morrison TG. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein. J Virol. 2015 Jul; 89(13):6835-47. PMID: 25903340.
      View in: PubMed
    5. Ogembo JG, Muraswki MR, McGinnes LW, Parcharidou A, Sutiwisesak R, Tison T, Avendano J, Agnani D, Finberg RW, Morrison TG, Fingeroth JD. A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice. J Transl Med. 2015 Feb 06; 13:50. PMID: 25885535.
      View in: PubMed
    6. Schmidt MR, McGinnes-Cullen LW, Kenward SA, Willems KN, Woodland RT, Morrison TG. Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory. J Virol. 2014 Sep 1; 88(17):10165-76. PMID: 24965456.
      View in: PubMed
    7. Morrison TG. Meeting report VLPNPV: Session 3: Immune responses. Hum Vaccin Immunother. 2014; 10(10):3064-7. PMID: 25529229.
      View in: PubMed
    8. McGinnes LW, Morrison TG. Newcastle disease virus-like particles: preparation, purification, quantification, and incorporation of foreign glycoproteins. Curr Protoc Microbiol. 2013 Oct 02; 30:Unit 18.2.. PMID: 24510891.
      View in: PubMed
    9. Morrison TG, Walsh EE. Subunit and virus-like particle vaccine approaches for respiratory syncytial virus. Curr Top Microbiol Immunol. 2013; 372:285-306. PMID: 24362695.
      View in: PubMed
    10. Schmidt MR, McGinnes LW, Kenward SA, Willems KN, Woodland RT, Morrison TG. Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains. J Virol. 2012 Nov; 86(21):11654-62. PMID: 22896618.
      View in: PubMed
    11. Battisti AJ, Meng G, Winkler DC, McGinnes LW, Plevka P, Steven AC, Morrison TG, Rossmann MG. Structure and assembly of a paramyxovirus matrix protein. Proc Natl Acad Sci U S A. 2012 Aug 28; 109(35):13996-4000. PMID: 22891297.
      View in: PubMed
    12. Gravel KA, McGinnes LW, Reitter J, Morrison TG. The transmembrane domain sequence affects the structure and function of the Newcastle disease virus fusion protein. J Virol. 2011 Apr; 85(7):3486-97. PMID: 21270151.
      View in: PubMed
    13. McGinnes LW, Gravel KA, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Schmidt MR, Morrison TG. Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins. J Virol. 2011 Jan; 85(1):366-77. PMID: 20980510.
      View in: PubMed
    14. Morrison TG. Newcastle disease virus-like particles as a platform for the development of vaccines for human and agricultural pathogens. Future Virol. 2010 Sep 01; 5(5):545-554. PMID: 21339837.
      View in: PubMed
    15. McGinnes LW, Pantua H, Laliberte JP, Gravel KA, Jain S, Morrison TG. Assembly and biological and immunological properties of Newcastle disease virus-like particles. J Virol. 2010 May; 84(9):4513-23. PMID: 20181713.
      View in: PubMed
    16. Murawski MR, McGinnes LW, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Heaton PM, Fraire AE, Morrison TG. Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology. J Virol. 2010 Jan; 84(2):1110-23. PMID: 19889768.
      View in: PubMed
    17. Jain S, McGinnes LW, Morrison TG. Role of thiol/disulfide exchange in newcastle disease virus entry. J Virol. 2009 Jan; 83(1):241-9. PMID: 18922867.
      View in: PubMed
    18. Jain S, McGinnes LW, Morrison TG. Overexpression of thiol/disulfide isomerases enhances membrane fusion directed by the Newcastle disease virus fusion protein. J Virol. 2008 Dec; 82(24):12039-48. PMID: 18829746.
      View in: PubMed
    19. Laliberte JP, McGinnes LW, Morrison TG. Incorporation of functional HN-F glycoprotein-containing complexes into newcastle disease virus is dependent on cholesterol and membrane lipid raft integrity. J Virol. 2007 Oct; 81(19):10636-48. PMID: 17652393.
      View in: PubMed
    20. Jain S, McGinnes LW, Morrison TG. Thiol/disulfide exchange is required for membrane fusion directed by the Newcastle disease virus fusion protein. J Virol. 2007 Mar; 81(5):2328-39. PMID: 17151113.
      View in: PubMed
    21. Laliberte JP, McGinnes LW, Peeples ME, Morrison TG. Integrity of membrane lipid rafts is necessary for the ordered assembly and release of infectious Newcastle disease virus particles. J Virol. 2006 Nov; 80(21):10652-62. PMID: 17041223.
      View in: PubMed
    22. Pantua HD, McGinnes LW, Peeples ME, Morrison TG. Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol. 2006 Nov; 80(22):11062-73. PMID: 16971425.
      View in: PubMed
    23. McGinnes LW, Pantua H, Reitter J, Morrison TG. Newcastle disease virus: propagation, quantification, and storage. Curr Protoc Microbiol. 2006 Jun; Chapter 15:Unit 15F.2. PMID: 18770579.
      View in: PubMed
    24. McGinnes LW, Morrison TG. Inhibition of receptor binding stabilizes Newcastle disease virus HN and F protein-containing complexes. J Virol. 2006 Mar; 80(6):2894-903. PMID: 16501098.
      View in: PubMed
    25. Pantua H, McGinnes LW, Leszyk J, Morrison TG. Characterization of an alternate form of Newcastle disease virus fusion protein. J Virol. 2005 Sep; 79(18):11660-70. PMID: 16140743.
      View in: PubMed
    26. Dolganiuc V, McGinnes L, Luna EJ, Morrison TG. Role of the cytoplasmic domain of the Newcastle disease virus fusion protein in association with lipid rafts. J Virol. 2003 Dec; 77(24):12968-79. PMID: 14645553.
      View in: PubMed
    27. Gravel KA, Morrison TG. Interacting domains of the HN and F proteins of newcastle disease virus. J Virol. 2003 Oct; 77(20):11040-9. PMID: 14512552.
      View in: PubMed
    28. Morrison TG. Structure and function of a paramyxovirus fusion protein. Biochim Biophys Acta. 2003 Jul 11; 1614(1):73-84. PMID: 12873767.
      View in: PubMed
    29. McGinnes LW, Reitter JN, Gravel K, Morrison TG. Evidence for mixed membrane topology of the newcastle disease virus fusion protein. J Virol. 2003 Feb; 77(3):1951-63. PMID: 12525629.
      View in: PubMed
    30. McGinnes LW, Gravel K, Morrison TG. Newcastle disease virus HN protein alters the conformation of the F protein at cell surfaces. J Virol. 2002 Dec; 76(24):12622-33. PMID: 12438588.
      View in: PubMed
    31. McGinnes LW, Sergel T, Chen H, Hamo L, Schwertz S, Li D, Morrison TG. Mutational analysis of the membrane proximal heptad repeat of the newcastle disease virus fusion protein. Virology. 2001 Oct 25; 289(2):343-52. PMID: 11689056.
      View in: PubMed
    32. Sergel TA, McGinnes LW, Morrison TG. Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the Newcastle disease virus fusion protein. J Virol. 2001 Sep; 75(17):7934-43. PMID: 11483738.
      View in: PubMed
    33. McGinnes L, Sergel T, Reitter J, Morrison T. Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity. Virology. 2001 May 10; 283(2):332-42. PMID: 11336558.
      View in: PubMed
    34. Morrison TG. The three faces of paramyxovirus attachment proteins. Trends Microbiol. 2001 Mar; 9(3):103-5. PMID: 11239770.
      View in: PubMed
    35. Sergel TA, McGinnes LW, Morrison TG. A single amino acid change in the Newcastle disease virus fusion protein alters the requirement for HN protein in fusion. J Virol. 2000 Jun; 74(11):5101-7. PMID: 10799584.
      View in: PubMed
    36. Young JK, Li D, Abramowitz MC, Morrison TG. Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions. J Virol. 1999 Jul; 73(7):5945-56. PMID: 10364347.
      View in: PubMed
    37. Stone-Hulslander J, Morrison TG. Mutational analysis of heptad repeats in the membrane-proximal region of Newcastle disease virus HN protein. J Virol. 1999 May; 73(5):3630-7. PMID: 10196255.
      View in: PubMed
    38. Li Z, Sergel T, Razvi E, Morrison T. Effect of cleavage mutants on syncytium formation directed by the wild-type fusion protein of Newcastle disease virus. J Virol. 1998 May; 72(5):3789-95. PMID: 9557661.
      View in: PubMed
    39. Young JK, Hicks RP, Wright GE, Morrison TG. The role of leucine residues in the structure and function of a leucine zipper peptide inhibitor of paramyxovirus (NDV) fusion. Virology. 1998 Mar 30; 243(1):21-31. PMID: 9527912.
      View in: PubMed
    40. McGinnes LW, Morrison TG. Role of carbohydrate processing and calnexin binding in the folding and activity of the HN protein of Newcastle disease virus. Virus Res. 1998 Feb; 53(2):175-85. PMID: 9620209.
      View in: PubMed
    41. Young JK, Hicks RP, Wright GE, Morrison TG. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling. Virology. 1997 Nov 24; 238(2):291-304. PMID: 9400602.
      View in: PubMed
    42. Stone-Hulslander J, Morrison TG. Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells. J Virol. 1997 Sep; 71(9):6287-95. PMID: 9261345.
      View in: PubMed
    43. McGinnes LW, Morrison TG. Disulfide bond formation is a determinant of glycosylation site usage in the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J Virol. 1997 Apr; 71(4):3083-9. PMID: 9060670.
      View in: PubMed
    44. McGinnes LW, Morrison TG. Role of cotranslational disulfide bond formation in the folding of the hemagglutinin-neuraminidase protein of Newcastle disease virus. Virology. 1996 Oct 15; 224(2):465-76. PMID: 8874507.
      View in: PubMed
    45. McGinnes LW, Morrison TG. The role of individual oligosaccharide chains in the activities of the HN glycoprotein of Newcastle disease virus. Virology. 1995 Oct 1; 212(2):398-410. PMID: 7571409.
      View in: PubMed
    46. Reitter JN, Sergel T, Morrison TG. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J Virol. 1995 Oct; 69(10):5995-6004. PMID: 7666504.
      View in: PubMed
    47. Sergel T, Morrison TG. Mutations in the cytoplasmic domain of the fusion glycoprotein of Newcastle disease virus depress syncytia formation. Virology. 1995 Jul 10; 210(2):264-72. PMID: 7618266.
      View in: PubMed
    48. McGinnes LW, Morrison TG. Modulation of the activities of HN protein of Newcastle disease virus by nonconserved cysteine residues. Virus Res. 1994 Dec; 34(3):305-16. PMID: 7856316.
      View in: PubMed
    49. Sergel-Germano T, McQuain C, Morrison T. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J Virol. 1994 Nov; 68(11):7654-8. PMID: 7933158.
      View in: PubMed
    50. McGinnes LW, Morrison TG. The role of the individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus. Virology. 1994 May 1; 200(2):470-83. PMID: 8178436.
      View in: PubMed
    51. McGinnes LW, Morrison TG. Conformationally sensitive antigenic determinants on the HN glycoprotein of Newcastle disease virus form with different kinetics. Virology. 1994 Mar; 199(2):255-64. PMID: 7510081.
      View in: PubMed
    52. Sergel T, McGinnes L, Morrison T. Role of a conserved sequence in the maturation and function of the NDV HN glycoprotein. Virus Res. 1993 Dec; 30(3):281-94. PMID: 8109161.
      View in: PubMed
    53. Sergel T, McGinnes LW, Morrison TG. The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity. Virology. 1993 Oct; 196(2):831-4. PMID: 8372451.
      View in: PubMed
    54. McGinnes L, Sergel T, Morrison T. Mutations in the transmembrane domain of the HN protein of Newcastle disease virus affect the structure and activity of the protein. Virology. 1993 Sep; 196(1):101-10. PMID: 8356787.
      View in: PubMed
    55. Morrison T, McQuain C, Sergel T, McGinnes L, Reitter J. The role of the amino terminus of F1 of the Newcastle disease virus fusion protein in cleavage and fusion. Virology. 1993 Apr; 193(2):997-1000. PMID: 8460504.
      View in: PubMed
    56. Sergel T, McGinnes LW, Peeples ME, Morrison TG. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology. 1993 Apr; 193(2):717-26. PMID: 8384752.
      View in: PubMed
    57. Wang C, Raghu G, Morrison T, Peeples ME. Intracellular processing of the paramyxovirus F protein: critical role of the predicted amphipathic alpha helix adjacent to the fusion domain. J Virol. 1992 Jul; 66(7):4161-9. PMID: 1602539.
      View in: PubMed
    58. Morrison T, McQuain C, McGinnes L. Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. J Virol. 1991 Feb; 65(2):813-22. PMID: 1987376.
      View in: PubMed
    59. Morrison T, Hinshaw VS, Sheerar M, Cooley AJ, Brown D, McQuain C, McGinnes L. Retroviral expressed hemagglutinin-neuraminidase protein protects chickens from Newcastle disease virus induced disease. Microb Pathog. 1990 Dec; 9(6):387-96. PMID: 1965848.
      View in: PubMed
    60. Morrison TG, McQuain C, O'Connell KF, McGinnes LW. Mature, cell-associated HN protein of Newcastle disease virus exists in two forms differentiated by posttranslational modifications. Virus Res. 1990 Feb; 15(2):113-33. PMID: 2321417.
      View in: PubMed
    61. Wilson C, Gilmore R, Morrison T. Aberrant membrane insertion of a cytoplasmic tail deletion mutant of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. Mol Cell Biol. 1990 Feb; 10(2):449-57. PMID: 2153915.
      View in: PubMed
    62. Morrison TG, McGinnes LW. Avian cells expressing the Newcastle disease virus hemagglutinin-neuraminidase protein are resistant to Newcastle disease virus infection. Virology. 1989 Jul; 171(1):10-7. PMID: 2545025.
      View in: PubMed
    63. Wilson C, Connolly T, Morrison T, Gilmore R. Integration of membrane proteins into the endoplasmic reticulum requires GTP. J Cell Biol. 1988 Jul; 107(1):69-77. PMID: 2839521.
      View in: PubMed
    64. Morrison TG. Structure, function, and intracellular processing of paramyxovirus membrane proteins. Virus Res. 1988 May; 10(2-3):113-35. PMID: 3046164.
      View in: PubMed
    65. McGinnes L, McQuain C, Morrison T. The P protein and the nonstructural 38K and 29K proteins of Newcastle disease virus are derived from the same open reading frame. Virology. 1988 May; 164(1):256-64. PMID: 3363866.
      View in: PubMed
    66. McGinnes LW, Wilde A, Morrison TG. Nucleotide sequence of the gene encoding the Newcastle disease virus hemagglutinin-neuraminidase protein and comparisons of paramyxovirus hemagglutinin-neuraminidase protein sequences. Virus Res. 1987 May; 7(3):187-202. PMID: 3037818.
      View in: PubMed
    67. Wilson C, Gilmore R, Morrison T. Translation and membrane insertion of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. Mol Cell Biol. 1987 Apr; 7(4):1386-92. PMID: 3600630.
      View in: PubMed
    68. Morrison TG, Peeples ME, McGinnes LW. Conformational change in a viral glycoprotein during maturation due to disulfide bond disruption. Proc Natl Acad Sci U S A. 1987 Feb; 84(4):1020-4. PMID: 3469645.
      View in: PubMed
    69. McGinnes LW, Morrison TG. The nucleotide sequence of the gene encoding the Newcastle disease virus membrane protein and comparisons of membrane protein sequences. Virology. 1987 Feb; 156(2):221-8. PMID: 3027973.
      View in: PubMed
    70. McGinnes LW, Morrison TG. Nucleotide sequence of the gene encoding the Newcastle disease virus fusion protein and comparisons of paramyxovirus fusion protein sequences. Virus Res. 1986 Sep; 5(4):343-56. PMID: 3776349.
      View in: PubMed
    71. Wilde A, McQuain C, Morrison T. Identification of the sequence content of four polycistronic transcripts synthesized in Newcastle disease virus infected cells. Virus Res. 1986 Jul; 5(1):77-95. PMID: 3755855.
      View in: PubMed
    72. Morrison TG, McGinnes LJ. Cytochalasin D accelerates the release of Newcastle disease virus from infected cells. Virus Res. 1985 Dec; 4(1):93-106. PMID: 4082779.
      View in: PubMed
    73. McGinnes LW, Semerjian A, Morrison T. Conformational changes in Newcastle disease virus fusion glycoprotein during intracellular transport. J Virol. 1985 Nov; 56(2):341-8. PMID: 3840536.
      View in: PubMed
    74. Morrison T, Ward LJ, Semerjian A. Intracellular processing of the Newcastle disease virus fusion glycoprotein. J Virol. 1985 Mar; 53(3):851-7. PMID: 3838349.
      View in: PubMed
    75. Wilde A, Morrison T. Structural and functional characterization of Newcastle disease virus polycistronic RNA species. J Virol. 1984 Jul; 51(1):71-6. PMID: 6726896.
      View in: PubMed
    76. Morrison TG, Ward LJ. Intracellular processing of the vesicular stomatitis virus glycoprotein and the Newcastle disease virus hemagglutinin-neuraminidase glycoprotein. Virus Res. 1984; 1(3):225-39. PMID: 6099658.
      View in: PubMed
    77. Chatis PA, Morrison TG. Characterization of the soluble glycoprotein released from vesicular stomatitis virus-infected cells. J Virol. 1983 Jan; 45(1):80-90. PMID: 6296461.
      View in: PubMed
    78. Chatis PA, Morrison TG. Fatty acid modification of Newcastle disease virus glycoproteins. J Virol. 1982 Jul; 43(1):342-7. PMID: 7109029.
      View in: PubMed
    79. Chatis PA, Morrison TG. Mutational changes in the vesicular stomatitis virus glycoprotein affect the requirement of carbohydrate in morphogenesis. J Virol. 1981 Jan; 37(1):307-16. PMID: 6260984.
      View in: PubMed
    80. Morrison TG, Simpson D. Synthesis, stability, and cleavage of Newcastle disease virus glycoproteins in the absence of glycosylation. J Virol. 1980 Oct; 36(1):171-80. PMID: 7441820.
      View in: PubMed
    81. Chatis PA, Morrison TG. Vesicular stomatitis virus glycoprotein is anchored to intracellular membranes near its carboxyl end and is proteolytically cleaved at its amino terminus. J Virol. 1979 Mar; 29(3):957-63. PMID: 221683.
      View in: PubMed
    82. Morrison TG, McQuain CO, Simpson D. Assembly of viral membranes: maturation of the vesicular stomatitis virus glycoprotein in the presence of tunicamycin. J Virol. 1978 Oct; 28(1):368-74. PMID: 212608.
      View in: PubMed
    83. Morrison TG, McQuain CO. Assembly of viral membranes: nature of the association of vesicular stomatitis virus proteins to membranes. J Virol. 1978 Apr; 26(1):115-25. PMID: 206719.
      View in: PubMed
    84. Clinkscales CW, Bratt MA, Morrison TG. Synthesis of Newcastle disease virus polypeptides in a wheat germ cell-free system. J Virol. 1977 Apr; 22(1):97-101. PMID: 853567.
      View in: PubMed
    85. Morrison TG, McQuain C. Assembly of viral membranes. I. Association of vesicular stomatitis virus membrane proteins and membranes in a cell-free system. J Virol. 1977 Feb; 21(2):451-8. PMID: 189082.
      View in: PubMed
    86. Hightower LE, Morrison TG, Bratt MA. Relationships among the polypeptides of Newcastle disease virus. J Virol. 1975 Dec; 16(6):1599-607. PMID: 1202248.
      View in: PubMed
    87. Morrison TG, Lodish HF. Recognition of protein synthesis initiation signals on bacteriophage ribonucleic acid by mammalian ribosomes. J Biol Chem. 1974 Sep 25; 249(18):5860-6. PMID: 4415493.
      View in: PubMed
    88. Morrison TG, Blumberg DD, Malamy MH. T7 protein synthesis in F' episome-containing cells: assignment of specific proteins to three translational groups. J Virol. 1974 Feb; 13(2):386-93. PMID: 4589855.
      View in: PubMed
    89. Morrison T, Stampfer M, Baltimore D, Lodish HF. Translation of vesicular stomatitis messenger RNA by extracts from mammalian and plant cells. J Virol. 1974 Jan; 13(1):62-72. PMID: 4359431.
      View in: PubMed
    90. Morrison TG, Lodish HF. Translation of bacteriophage Q RNA by cytoplasmic extracts of mammalian cells. Proc Natl Acad Sci U S A. 1973 Feb; 70(2):315-9. PMID: 4568725.
      View in: PubMed
    For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
    Morrison's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _